This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2025 Zacks Investment Research | 101 N Wacker Drive, Floor 15, Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +23.81% per year. These returns cover a period from January 1, 1988 through September 1, 2025. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
View All Zacks #1 Ranked Stocks
Zacks News
Why PRA Group Can Be a Smart Addition to Your Portfolio
by Zacks Equity Research
PRAA demonstrates long-term value generation from distressed debt purchases.
MarketAxess's 1Q25 Total Average Trading Volume Jumps to $42.9B
by Zacks Equity Research
MKTX experiences significant growth from the impact of single-dealer portfolio trades.
Should Value Investors Buy Atlanticus (ATLC) Stock?
by Zacks Equity Research
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.
Wall Street Analysts Predict a 29.87% Upside in Atlanticus (ATLC): Here's What You Should Know
by Zacks Equity Research
The consensus price target hints at a 29.9% upside potential for Atlanticus (ATLC). While empirical research shows that this sought-after metric is hardly effective, an upward trend in earnings estimate revisions could mean that the stock will witness an upside in the near term.
Are Investors Undervaluing Atlanticus (ATLC) Right Now?
by Zacks Equity Research
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.
Atlanticus Holdings Corporation (ATLC) Q4 Earnings Surpass Estimates
by Zacks Equity Research
Atlanticus (ATLC) delivered earnings and revenue surprises of 17.36% and 0.85%, respectively, for the quarter ended December 2024. Do the numbers hold clues to what lies ahead for the stock?
Guild Holdings Company (GHLD) Q4 Earnings Lag Estimates
by Zacks Equity Research
Guild (GHLD) delivered earnings and revenue surprises of -3.03% and 18.70%, respectively, for the quarter ended December 2024. Do the numbers hold clues to what lies ahead for the stock?
MBIA (MBI) Reports Q4 Loss, Tops Revenue Estimates
by Zacks Equity Research
MBIA (MBI) delivered earnings and revenue surprises of -336.36% and 31.82%, respectively, for the quarter ended December 2024. Do the numbers hold clues to what lies ahead for the stock?
UMH Properties (UMH) Matches Q4 FFO Estimates
by Zacks Equity Research
UMH (UMH) delivered FFO and revenue surprises of 0% and 0.44%, respectively, for the quarter ended December 2024. Do the numbers hold clues to what lies ahead for the stock?
Why Atlanticus (ATLC) is Poised to Beat Earnings Estimates Again
by Zacks Equity Research
Atlanticus (ATLC) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.
Atlanticus (ATLC) Stock Jumps 5.0%: Will It Continue to Soar?
by Zacks Equity Research
Atlanticus (ATLC) was a big mover last session on higher-than-average trading volume. The latest trend in earnings estimate revisions might help the stock continue moving higher in the near term.
Should Value Investors Buy Atlanticus (ATLC) Stock?
by Zacks Equity Research
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.
Atlanticus Holdings Corporation (ATLC) Q3 Earnings and Revenues Surpass Estimates
by Zacks Equity Research
Atlanticus (ATLC) delivered earnings and revenue surprises of 3.25% and 7.44%, respectively, for the quarter ended September 2024. Do the numbers hold clues to what lies ahead for the stock?
GoHealth (GOCO) Reports Q3 Loss, Tops Revenue Estimates
by Zacks Equity Research
GoHealth (GOCO) delivered earnings and revenue surprises of -16.93% and 11.67%, respectively, for the quarter ended September 2024. Do the numbers hold clues to what lies ahead for the stock?
TeraWulf (WULF) Soars 23.5%: Is Further Upside Left in the Stock?
by Zacks Equity Research
TeraWulf (WULF) was a big mover last session on higher-than-average trading volume. The latest trend in earnings estimate revisions might not help the stock continue moving higher in the near term.
NerdWallet, Inc. (NRDS) Reports Break-Even Earnings for Q3
by Zacks Equity Research
NerdWallet, Inc. (NRDS) delivered earnings and revenue surprises of -100% and 10%, respectively, for the quarter ended September 2024. Do the numbers hold clues to what lies ahead for the stock?
Community West Bancshares (CWBC) Lags Q3 Earnings and Revenue Estimates
by Zacks Equity Research
Community West Bancshares (CWBC) delivered earnings and revenue surprises of -21.05% and 5.70%, respectively, for the quarter ended September 2024. Do the numbers hold clues to what lies ahead for the stock?
Runway Growth Finance Corp. (RWAY) Q2 Earnings and Revenues Lag Estimates
by Zacks Equity Research
Runway Growth Finance Corp. (RWAY) delivered earnings and revenue surprises of -13.95% and 9.11%, respectively, for the quarter ended June 2024. Do the numbers hold clues to what lies ahead for the stock?
Analysts Estimate Atlanticus Holdings Corporation (ATLC) to Report a Decline in Earnings: What to Look Out for
by Zacks Equity Research
Atlanticus (ATLC) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
HA Sustainable Infrastructure Capital (HASI) Beats Q2 Earnings and Revenue Estimates
by Zacks Equity Research
HA Sustainable Infrastructure Capital (HASI) delivered earnings and revenue surprises of 8.62% and 26.53%, respectively, for the quarter ended June 2024. Do the numbers hold clues to what lies ahead for the stock?
Synchrony (SYF) Boosts Financing Options With Atlanticus
by Zacks Equity Research
Synchrony (SYF) expands its partnership with Atlanticus in a bid to attract a large customer base and enhance customer experience.
Royalty Pharma (RPRX) Beats Q1 Earnings and Revenue Estimates
by Zacks Equity Research
Royalty Pharma (RPRX) delivered earnings and revenue surprises of 2.08% and 6.79%, respectively, for the quarter ended March 2024. Do the numbers hold clues to what lies ahead for the stock?
How Should You Play MarketAxess (MKTX) Ahead of Q1 Earnings?
by Zacks Equity Research
MarketAxess' (MKTX) strong liquidity not only safeguards its balance sheet but also facilitates agile capital deployment.
Here's What to Expect From Assurant's (AIZ) Q1 Earnings
by Zacks Equity Research
Assurant's (AIZ) first-quarter performance is likely to have benefited from higher yields in fixed maturity securities, lender-placed average insured values and organic growth across all products.
Is a Beat in Store for Cboe Global (CBOE) in Q1 Earnings?
by Zacks Equity Research
Cboe Global's (CBOE) Q1 results are likely to reflect improved index options trading volumes, higher physical port fees and proprietary market data fees, as well as strong proprietary products.